HomeCompareLBTSF vs MO

LBTSF vs MO: Dividend Comparison 2026

LBTSF yields 1.34% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LBTSF wins by $12.81M in total portfolio value
10 years
LBTSF
LBTSF
● Live price
1.34%
Share price
$15.35
Annual div
$0.21
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.89M
Annual income
$11,275,798.89
Full LBTSF calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — LBTSF vs MO

📍 LBTSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBTSFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBTSF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LBTSF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBTSF
Annual income on $10K today (after 15% tax)
$114.07/yr
After 10yr DRIP, annual income (after tax)
$9,584,429.06/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, LBTSF beats the other by $9,559,805.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBTSF + MO for your $10,000?

LBTSF: 50%MO: 50%
100% MO50/50100% LBTSF
Portfolio after 10yr
$6.48M
Annual income
$5,652,383.71/yr
Blended yield
87.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

LBTSF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
3.0
Piotroski
7/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBTSF buys
0
MO buys
0
No recent congressional trades found for LBTSF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBTSFMO
Forward yield1.34%6.27%
Annual dividend / share$0.21$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%22.6%
Portfolio after 10y$12.89M$77.7K
Annual income after 10y$11,275,798.89$28,968.54
Total dividends collected$12.74M$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: LBTSF vs MO ($10,000, DRIP)

YearLBTSF PortfolioLBTSF Income/yrMO PortfolioMO Income/yrGap
1← crossover$10,968$268.40$10,558$768.31+$410.00LBTSF
2$12,286$550.27$11,352$1,015.87+$934.00LBTSF
3$14,299$1,152.15$12,482$1,367.86+$1.8KLBTSF
4$17,806$2,506.24$14,103$1,883.39+$3.7KLBTSF
5$24,886$5,833.59$16,472$2,664.91+$8.4KLBTSF
6$41,867$15,239.53$20,024$3,897.79+$21.8KLBTSF
7$92,721$47,922.73$25,537$5,933.74+$67.2KLBTSF
8$297,587$198,376.17$34,478$9,476.77+$263.1KLBTSF
9$1,508,490$1,190,071.76$49,776$16,022.63+$1.46MLBTSF
10$12,889,884$11,275,798.89$77,699$28,968.54+$12.81MLBTSF

LBTSF vs MO: Complete Analysis 2026

LBTSFStock

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Full LBTSF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this LBTSF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBTSF vs SCHDLBTSF vs JEPILBTSF vs OLBTSF vs KOLBTSF vs MAINLBTSF vs PMLBTSF vs BTILBTSF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.